切尔诺贝利核事故后暴露于电离辐射患者的骨髓增殖性肿瘤特征
该研究纳入281例乌克兰电离辐射暴露与未暴露的骨髓增殖性肿瘤(MPN)患者,比较驱动突变谱。暴露组JAK2 V617F比例更低(58.4% vs 75.4%,P=.0077),1型样CALR突变比例更高(12.2% vs 3.1%,P=.0056),三阴性病例比例更高(27.8% vs 16.2%,P=.0366),潜在致病序列变异平均数量更多(4.8 vs 3.1,P=.0242),并发现暴露组三阴性MPN患者若干潜在驱动变异。
要点
- 电离辐射暴露MPN患者JAK2 V617F比例低于未暴露组(58.4% vs 75.4%,P=.0077)。
- 暴露组1型样CALR突变比例高于未暴露组(12.2% vs 3.1%,P=.0056)。
- 暴露组三阴性MPN比例高于未暴露组(27.8% vs 16.2%,P=.0366)。
核心结论
- 电离辐射暴露的MPN患者构成一个具有独特基因组特征的群体,值得进一步研究。
研究设计与样本
- 研究纳入281例乌克兰电离辐射暴露与未暴露的MPN患者,从外周血白细胞提取基因组DNA。
- 采用Sanger测序和实时聚合酶链反应检测JAK2 V617F、MPL W515及1型和2型样CALR突变。
- 采用寡核苷酸SNP微阵列平台评估染色体改变,并通过全外显子组和靶向测序鉴定其他遗传变异。
- 统计显著性采用Fisher精确检验和Wilcoxon秩和检验评估(R软件3.4.2版)。
主要发现
- 暴露组JAK2 V617F比例低于未暴露组(58.4% vs 75.4%,P=.0077)。
- 暴露组1型样CALR突变比例高于未暴露组(12.2% vs 3.1%,P=.0056)。
- 暴露组三阴性病例比例高于未暴露组(27.8% vs 16.2%,P=.0366)。
- 暴露组潜在致病序列变异平均数量多于未暴露组(4.8 vs 3.1,P=.0242)。
- 在暴露组三阴性MPN患者中鉴定出若干潜在驱动变异:ATM p.S1691R伴11q拷贝中性杂合性缺失;EZH2 p.D659G伴7q拷贝数丢失;SUZ12 p.V71M伴17q拷贝数丢失。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文结论指出电离辐射暴露MPN患者具有独特基因组特征,值得进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Myeloproliferative neoplasms (MPNs) driver mutations are usually found in JAK2, MPL, and CALR genes; however, 10%-15% of cases are triple negative (TN). A previous study showed lower rate of JAK2 V617F in primary myelofibrosis patients exposed to low doses of ionizing radiation (IR) from Chernobyl accident. To examine distinct driver mutations, we enrolled 281 Ukrainian IR-exposed and unexposed MPN patients. Genomic DNA was obtained from peripheral blood leukocytes. JAK2 V617F, MPL W515, types 1- and 2-like CALR mutations were identified by Sanger Sequencing and real time polymerase chain reaction. Chromosomal alterations were assessed by oligo-SNP microarray platform. Additional genetic variants were identified by whole exome and targeted sequencing. Statistical significance was evaluated by Fisher's exact test and Wilcoxon's rank sum test (R, version 3.4.2). IR-exposed MPN patients exhibited a different genetic profile vs unexposed: lower rate of JAK2 V617F (58.4% vs 75.4%, P = .0077), higher rate of type 1-like CALR mutation (12.2% vs 3.1%, P = .0056), higher rate of TN cases (27.8% vs 16.2%, P = .0366), higher rate of potentially pathogenic sequence variants (mean numbers: 4.8 vs 3.1, P = .0242). Furthermore, we identified several potential drivers specific to IR-exposed TN MPN patients: ATM p.S1691R with copy-neutral loss of heterozygosity at 11q; EZH2 p.D659G at 7q and SUZ12 p.V71 M at 17q with copy number loss. Thus, IR-exposed MPN patients represent a group with distinct genomic characteristics worthy of further study.
引用
- Poluben L, Puligandla M, Neuberg D, et al. Characteristics of myeloproliferative neoplasms in patients exposed to ionizing radiation following the Chernobyl nuclear accident. Am J Hematol. 2018. PMID: 30295334. doi:10.1002/ajh.25307
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。